UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

of the Securities Exchange Act of 1934

Date of Report: June 30, 2020

Commission File Number: 001-36891

 

 

Cellectis S.A.

(Exact Name of registrant as specified in its charter)

 

 

8, rue de la Croix Jarry

75013 Paris, France

+33 1 81 69 16 00

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F  ☒            Form 40-F  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ☐

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):  ☐

 

 

 

General Meeting

Cellectis S.A. (the “Company”) held its Combined Ordinary and Extraordinary General Meeting (the “Meeting”) on June 29, 2020. Filed as Exhibits 99.1 and 99.2 hereto are the press release and the voting results for the Meeting, respectively.

EXHIBIT INDEX

 

Exhibit

   

Title

99.1    Press Release, dated June 29, 2020.
99.2    Voting Results for the Combined Ordinary and Extraordinary General Meeting.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

   

CELLECTIS S.A.

(Registrant)

June 30, 2020     By:  

/s/ André Choulika

      André Choulika
      Chief Executive Officer
EX-99.1

Exhibit 99.1

 

LOGO

PRESS RELEASE

Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 29, 2020

June 29, 2020 – New York – Cellectis S.A. held its Annual Shareholders’ General Meeting (Euronext Growth: ALCLS – Nasdaq: CLLS) was held on June 29, 2020 at its head office in Paris, France.

At the meeting, during which more than 63% of voting rights were exercised, Resolutions 1 through 22, and Resolutions 26 through 28 were adopted. Resolutions 23, 24, 25 and 29 were rejected. The detailed results of the vote and the resolutions are available on the company’s website: https://www.cellectis.com/en/investors/general-meetings/

About Cellectis

Cellectis is developing the first of its kind allogeneic approach for CAR-T immunotherapies in oncology, pioneering the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells to treat cancer patients. As a clinical-stage biopharmaceutical company with over 20 years of expertise in gene editing, Cellectis is developing life-changing product candidates utilizing TALEN®, its gene editing technology, and PulseAgile, its pioneering electroporation system to harness the power of the immune system in order to target and eradicate cancer cells.

As part of its commitment to a cure, Cellectis remains dedicated to its goal of providing life-saving UCART product candidates to address unmet needs for multiple cancers including acute myeloid leukemia (AML), B-cell acute lymphoblastic leukemia (B-ALL) and multiple myeloma (MM).

Cellectis headquarters are in Paris, France, with additional locations in New York, New York and Raleigh, North Carolina. Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on Euronext Growth (ticker: ALCLS). For more information, visit www.cellectis.com.

Follow Cellectis on social media: @cellectis, LinkedIn and YouTube.

TALEN® is a registered trademark owned by Cellectis.

For further information, please contact:

Media contacts:

Jennifer Moore, VP of Communications, 917-580-1088, media@cellectis.com

Caitlin Kasunich, KCSA Strategic Communications, 212-896-1241, ckasunich@kcsa.com

IR contact:

Simon Harnest, VP of Corporate Strategy and Finance, 646-385-9008, simon.harnest@cellectis.com

###

EX-99.2

Exhibit 99.2

CELLECTIS - GENERAL ASSEMBLY - 06/29/2020

VOTE RESULTS

Ordinary Resolutions

 

                       
 Nb       Resolution    Result   For   Against   Vote
withhold		   Total votes    Shares represented 
by the votes cast		  

Percentage of the
share capital
 represented by the 
votes cast

 

   Out of vote
 voting rights 		    Null voting 
rights 		    Quorum 
 

 

Votes

   %   Votes     %     Votes    % 
 1     

 

Approval of the financial statements for the financial year ended December 31, 2019.

 

   1   

 

 Carried 

    32 296 425     99,93 %     24 127     0,07 %    26 074     -     32 320 552     27 106 620    63,801 %   0   0   63,801 %
                                                         
 2     

 

Approval of the consolidated financial statements for the financial year ended December 31, 2019.

 

  2  

 

Carried

   32 297 425   99,93 %   24 127    0,07 %   25 074   -   32 321 552   27 106 620   63,801 %   0   0   63,801 %
                                                         
 3     

 

Allocation of income for the financial year ended December 31, 2019.

 

  3  

 

Carried

   32 313 406   99,91 %   27 654    0,09 %   5 566   -   32 341 060   27 106 620   63,801 %   0   0   63,801 %
                                                         
 4     

 

Approval of the agreements referred to in articles L. 225-38 and the following sections of the French commercial code.

 

  4  

 

Carried

   25 155 570   77,79 %   7 181 381   22,21 %   9 675   -   32 336 951   27 106 620   63,801 %   0   0   63,801 %
                                                         
 5     

 

Setting the amount of the total compensation (directors fees) to be granted to the non-executive directors.

 

  5  

 

Carried

   32 228 592   99,69 %   101 331    0,31 %   16 703   -   32 329 923   27 106 620   63,801 %   0   0   63,801 %
                                                         
 6     

 

Renewal of the mandate of a member of the Board of Directors of Mrs. Annick Schwebig.

 

  6  

 

Carried

   27 709 202   85,68 %   4 631 465   14,32 %   5 959   -   32 340 667   27 106 620   63,801 %   0   0   63,801 %
                                                         

CELLECTIS - GENERAL ASSEMBLY - 06/29/2020

VOTE RESULTS

 

Ordinary Resolutions

 

                       
 Nb       Resolution    Result   For   Against   Vote
withhold		   Total votes    Shares represented 
by the votes cast		  

Percentage of the
share capital
 represented by the 
votes cast

 

   Out of vote
 voting rights 		    Null voting 
rights 		    Quorum 
 

 

Votes

   %   Votes     %     Votes    % 
   
7  

 

Renewal of the mandate of a member of the Board of Directors of Mr. Laurent Arthaud.

 

                                                       
  7    Carried     28 206 474     87,22 %     4 132 979     12,78 %     7 173     -      32 339 453     27 106 620   63,801 %   0   0   63,801 %
                                                       
8  

 

Renewal of the mandate of a member of the Board of Directors of Mr. Pierre Bastid.

 

                                                       
  8   Carried   27 987 046   86,54 %   4 352 407   13,46 %   7 173   -   32 339 453   27 106 620   63,801 %   0   0   63,801 %
                                                       
9  

 

Renewal of the mandate of a member of the Board of Directors of Mr. Rainer Boehm.

 

                                                       
  9   Carried   28 504 457   88,14 %   3 834 986   11,86 %   7 183   -   32 339 443   27 106 620   63,801 %   0   0   63,801 %
                                                       
10  

 

Renewal of the mandate of a member of the Board of Directors of Mr. Hervé Hoppenot.

 

                                                       
  10   Carried   27 920 532   86,34 %   4 419 029   13,66 %   7 065   -   32 339 561   27 106 620   63,801 %   0   0   63,801 %
                                                       
11  

 

Authorization to be given to the board of directors to buy back Company shares.

 

                                                       
  11   Carried   29 519 026   91,30 %   2 814 240   8,70 %    13 360    -   32 333 266   27 106 620   63,801 %   0   0   63,801 %
                                                       

CELLECTIS - GENERAL ASSEMBLY - 06/29/2020

VOTE RESULTS

 

Extraordinary Resolutions

 

                       
 Nb       Resolution    Result   For   Against   Vote
withhold		   Total votes    Shares represented 
by the votes cast		  

Percentage of the
share capital
 represented by the 
votes cast

 

   Out of vote
 voting rights 		    Null voting 
rights 		    Quorum 
 

 

Votes

   %   Votes     %     Votes    % 
 12     

 

Authorization to be given to the board of directors for the purpose of reducing the share capital through the cancellation of shares in the context of the authorization to buy back its own shares.

 

   12   

 

 Carried 

    32 220 812     99,71 %     93 329     0,29 %    32 485     -     32 314 141     27 106 620    63,801 %   0   0   63,801 %
                                                         
 13     

 

Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by issuing ordinary shares and /or any securities, with a waiver of the preferential subscription rights of the shareholders, in favor of categories of persons meeting specified characteristics.

 

  13  

 

Carried

   21 646 301   66,99 %   10 667 880    33,01 %    32 445   -   32 314 181   27 106 620   63,801 %   0   0   63,801 %
                                                         
 14     

 

Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by issuing ordinary shares and /or any securities, with a waiver of the preferential subscription rights of the shareholders, in favor of a first category of persons meeting specified characteristics.

 

  14  

 

Carried

   21 643 493   66,98 %    10 669 855     33,02 %    33 278   -   32 313 348   27 106 620   63,801 %   0   0   63,801 %
                                                         
 15     

 

Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by issuing ordinary shares and /or any securities, with a waiver of the preferential subscription rights of the shareholders, in favor of a second category of persons meeting specified characteristics.

 

  15  

 

Carried

   21 643 623   66,98 %   10 669 235   33,02 %   33 768   -   32 312 858   27 106 620   63,801 %   0   0   63,801 %
                                                         
 16     

 

Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital through the issuance of ordinary shares or of any securities with a waiver of the preferential subscription rights, in favor of a category of persons taking part to a line equity financing or bond financing.

 

  16  

 

Carried

   21 644 220   66,98 %   10 668 638    33,02 %   33 768   -   32 312 858   27 106 620   63,801 %   0   0   63,801 %
                                                         
 17     

 

Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital immediately or in the future by issuing ordinary shares or any securities, while maintaining the preferential subscription rights of shareholders.

 

  17  

 

Carried

   25 221 209   78,05 %   7 091 761   21,95 %   33 656   -   32 312 970   27 106 620   63,801 %   0   0   63,801 %
                                                         

CELLECTIS - GENERAL ASSEMBLY - 06/29/2020

VOTE RESULTS

 

Extraordinary Resolutions

 

                       
 Nb       Resolution    Result   For   Against   Vote
withhold		   Total votes    Shares represented 
by the votes cast		  

Percentage of the
share capital
 represented by the 
votes cast

 

   Out of vote
 voting rights 		    Null voting 
rights 		    Quorum 
 

 

Votes

   %   Votes     %     Votes    % 
18  

 

Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital through the issuance of ordinary shares and /or any securities, with waiver of the preferential subscription rights of the shareholders, through a public offering.

 

   18   

 

 Carried 

    21 642 870     66,98 %     10 670 821     33,02 %     32 935     -     32 313 691     27 106 620    63,801 %   0   0   63,801 %
                                                         
19  

 

Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital through the issuance of ordinary shares and /or of any securities, with waiver of the preferential subscription rights of the shareholders, through an offer referred to in Article L. 411-2 of the French monetary and financial code.

 

  19  

 

Carried

   21 664 489   67,04 %   10 649 202   32,96 %   32 935    -    32 313 691   27 106 620   63,801 %   0   0   63,801 %
                                                         
20  

 

Delegation granted to the board of directors to increase the number of securities to be issued in case of share capital increase with or without preferential subscription rights.

 

  20  

 

Carried

   21 772 204   67,38 %   10 541 422   32,62 %   33 000    -    32 313 626   27 106 620   63,801 %   0   0   63,801 %
                                                         
21  

 

Overall limitations to the amount of issuances made under the 13th to 15th resolutions, the 16th resolution, the 17th resolution, 18th resolution, the 19th resolution and the 20th resolution above.

 

  21  

 

Carried

   27 949 605   86,49 %   4 365 566   13,51 %   31 455    -    32 315 171   27 106 620   63,801 %   0   0   63,801 %
                                                         
22  

 

Delegation of authority to be granted to the board of directors for the purpose of increasing the share capital by incorporation of premiums, reserves, profits or others.

 

  22  

 

Carried

   32 271 499   99,87 %   41 792   0,13 %   33 335    -    32 313 291   27 106 620   63,801 %   0   0   63,801 %
                                                         
23  

 

Authorization to be given to the board of directors to grant options to subscribe or purchase Company’s shares.

 

  23  

 

 Rejected 

   17 582 188   54,40 %   14 737 830   45,60 %   26 608    -    32 320 018   27 106 620   63,801 %   0   0   63,801 %
                                                         

CELLECTIS - GENERAL ASSEMBLY - 06/29/2020

VOTE RESULTS

 

Extraordinary Resolutions

 

                       
 Nb       Resolution    Result   For   Against   Vote
withhold		   Total votes    Shares represented 
by the votes cast		  

Percentage of the
share capital
 represented by the 
votes cast

 

   Out of vote
 voting rights 		    Null voting 
rights 		    Quorum 
 

 

Votes

   %   Votes     %     Votes    % 
 24     

 

Authorization be given to the board of directors for the allocation of free shares existing and/or to be issued in the future.

 

   24   

 

 Rejected 

    17 748 878     54,93 %      14 563 783     45,07 %     33 965     -     32 312 661     27 106 620    63,801 %   0   0   63,801 %
                                                         
 25     

 

Delegation of authority to be granted to the board of directors to issue warrants giving the right to subscribe ordinary shares of the Company - Cancellation of the preferential right of subscription to the benefit of a category of persons meeting specific characteristics.

 

  25  

 

Rejected

   17 788 564   55,05 %   14 524 427    44,95 %    33 635   -   32 312 991   27 106 620   63,801 %   0   0   63,801 %
                                                         
 26     

 

Overall limitations to the amount of issues made under the 23rd resolution, 24st resolution and the 25th resolution above.

 

  26  

 

Carried

   28 057 540   86,82 %   4 257 823    13,18 %    31 263   -   32 315 363   27 106 620   63,801 %   0   0   63,801 %
                                                         
 27     

 

Amendment of article 12 of the articles of association “meeting of the board of directors” in order to provide for the possibility for the board of directors to take certain decisions by means of written consultation.

 

  27  

 

Carried

   32 275 062   99,88 %   37 412   0,12 %   34 152   -   32 312 474   27 106 620   63,801 %   0   0   63,801 %
                                                         
 28     

 

Amendment of Article 18 of the Articles of Association “General Meetings - quorum - voting - number of votes” in order to update the legal provisions concerning the procedures for determining the majority required for the adoption of resolutions by general meetings of shareholders.

 

  28  

 

Carried

   32 274 711   99,89 %   36 987    0,11 %   34 928   -   32 311 698   27 106 620   63,801 %   0   0   63,801 %
                                                         
 29     

 

Delegation to be granted to the board of directors for the purpose of an increase in the share capital whose subscription would be reserved to members of a company savings plan established pursuant to articles L. 3332-1 and following of the French labor code.

 

  29  

 

Rejected

   16 986 839   52,58 %   15 317 068   47,42 %   42 719   -   32 303 907   27 106 620   63,801 %   0   0   63,801 %